AutoCruitment has been sold to QHP Capital
AutoCruitment offers a transparent metrics-driven ecosystem of global, risk-based patient recruitment and engagement solutions, digitizing and revolutionizing the end-to-end patient and client experience. Its multifaceted approach utilizes sophisticated algorithms, advanced automation and over 1,500 direct-to-patient online channels to directly find, screen and automatically refer highly qualified patients across all therapeutic areas with a greater chance of randomization success. AutoCruitment’s patient recruitment scientists collaborate with pharma, biotech and contract research organization (CRO) project teams, while supporting research sites to optimize recruitment and increase randomization by an average of 97% per month. The results are higher enrollment, increased diversity and greater patient engagement, accelerating timelines and exceeding milestones at every phase of clinical research. For more information, please visit www.autocruitment.com.
Lincoln International acted as exclusive financial advisor to AutoCruitment, providing guidance to the company and its founders going through a sale process for the first time. This included providing insights to the company on the market landscape, buyer universe, deal structure alternatives and transaction environment. Lincoln leveraged its deep industry knowledge of the outsourced pharmaceutical services market and expansive reach across corporate buyers and private equity investors to achieve a successful outcome for the sellers.
Since its founding in 2013, AutoCruitment has quickly grown under the leadership of Bethany Bray, a Founder and the Chief Executive Officer, into the leading global digital solution in clinical trial patient recruitment. It was critical to the founders to find a partner who understood the clinical research space and was best equipped to support the next stage of growth for AutoCruitment.
Bethany commented, “It was a true honor working alongside the Lincoln team. From our initial call to deal close they acted as an extension of our team, continually guiding us through the process, providing deep knowledge and support at every junction. Lincoln’s dedication to their clients, invaluable insights and relationships and true white-glove service are second to none. Lincoln was instrumental in AutoCruitment securing the perfect partner to help turbocharge the AutoCruitment vision and mission, and they have our highest level of recommendation.”
Tony Crisman, Managing Director in Lincoln’s Healthcare Group, added, “Working with founders that have the passion and vision to build a platform like AutoCruitment is a true privilege. What Bethany and the AutoCruitment team have achieved to date is unprecedented and unmatched in the pharma services sector today. There is a high degree of alignment between AutoCruitment and NovaQuest, so the next chapter of growth and development is going to be exciting to watch. The future is bright for AutoCruitment.”
QHP Capital is a leading investor in technology and services companies in the life sciences and healthcare sectors. QHP Capital spun out of NovaQuest Capital Management, which was formed in 2000 with the vision of building an investment platform to provide strategic capital and industry expertise in partnership with strong management teams. The investment team consists of seasoned investment and operational professionals with significant investment experience and deep life science and healthcare expertise. QHP benefits from an extensive network of industry experts and relationships that assist in identifying, analyzing and growing QHP’s portfolio companies. QHP continues as the investment manager for NovaQuest Private Equity’s funds. For more information, please visit www.qhpcapital.com.
Lincoln's dedication to their clients, invaluable insights and relationships and true white-glove service are second to none.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised Seven Hills Capital on raising capital for Reliable Medical
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.